
Formosa Laboratories Inc
TWSE:4746

Formosa Laboratories Inc
Interest Income Expense
Formosa Laboratories Inc
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Formosa Laboratories Inc
TWSE:4746
|
Interest Income Expense
-NT$1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Interest Income Expense
NT$237.9m
|
CAGR 3-Years
217%
|
CAGR 5-Years
53%
|
CAGR 10-Years
13%
|
|
![]() |
ScinoPharm Taiwan Ltd
TWSE:1789
|
Interest Income Expense
NT$45.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Interest Income Expense
-NT$17.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Interest Income Expense
NT$224.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Interest Income Expense
NT$47.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

See Also
What is Formosa Laboratories Inc's Interest Income Expense?
Interest Income Expense
-1.2B
TWD
Based on the financial report for Sep 30, 2024, Formosa Laboratories Inc's Interest Income Expense amounts to -1.2B TWD.